SHUTTLE PHARMACEUTICALS HOLDINGS, INC.: 10-Q filed 2024-11-13
What SHUTTLE PHARMACEUTICALS HOLDINGS, INC. reported in its quarterly report filed 2024-11-13 (fiscal Q3 2024): 32 published measures, 93 facts as tagged in accession 0001493152-24-045176.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2024-11-13
- Fiscal period
- fiscal Q3 2024
- Accession
- 0001493152-24-045176 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SHUTTLE PHARMACEUTICALS HOLDINGS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 673,568 | USD | |
| At 2023-12-31 | 5,951,736 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 1,988,945 | USD | |
| At 2023-12-31 | 1,895,965 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | -1,315,377 | USD | |
| At 2024-06-30 | 801,434 | USD | |
| At 2024-03-31 | 2,761,487 | USD | |
| At 2023-12-31 | 4,055,771 | USD | |
| At 2023-09-30 | 5,609,749 | USD | |
| At 2023-06-30 | 6,935,610 | USD | |
| At 2023-03-31 | 6,906,468 | USD | |
| At 2022-12-31 | 7,677,869 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 156,656 | USD | |
| At 2023-12-31 | 2,576,416 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -3,784,082 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -7,546,328 | USD | 274 |
| 2024-04-01 to 2024-06-30 | -2,031,215 | USD | 91 |
| 2024-01-01 to 2024-03-31 | -1,731,031 | USD | 91 |
| 2023-07-01 to 2023-09-30 | -1,792,754 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -4,952,223 | USD | 273 |
| 2023-04-01 to 2023-06-30 | -2,184,372 | USD | 91 |
| 2023-01-01 to 2023-03-31 | -975,097 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | -4,637,068 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -4,518,973 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-09-30 | 19,046 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | -698,457 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 2,904,527 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 2,915,765 | USD | 274 |
| 2023-01-01 to 2023-09-30 | -2,916,760 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | -32,979,632 | USD | |
| At 2023-12-31 | -25,433,304 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 2,384,177 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 2,189,366 | shares | 274 |
| 2023-07-01 to 2023-09-30 | 1,969,904 | shares | 92 |
| 2023-01-01 to 2023-09-30 | 1,820,006 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 2,384,177 | shares | 92 |
| 2024-01-01 to 2024-09-30 | 2,189,366 | shares | 274 |
| 2023-07-01 to 2023-09-30 | 1,969,904 | shares | 92 |
| 2023-01-01 to 2023-09-30 | 1,820,006 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -1.59 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -3.45 | USD/shares | 274 |
| 2023-07-01 to 2023-09-30 | -0.91 | USD/shares | 92 |
| 2023-01-01 to 2023-09-30 | -2.72 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -1.59 | USD/shares | 92 |
| 2024-01-01 to 2024-09-30 | -3.45 | USD/shares | 274 |
| 2023-07-01 to 2023-09-30 | -0.91 | USD/shares | 92 |
| 2023-01-01 to 2023-09-30 | -2.72 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 21,160 | USD | |
| At 2023-12-31 | 24,827 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 227,886 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 95,438 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -3,051,561 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -5,919,042 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -1,599,146 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -4,609,558 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 361,351 | USD | |
| At 2023-12-31 | 5,593,005 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-07-01 to 2023-09-30 | 623,465 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 1,952,147 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 1,659,233 | USD | |
| At 2023-12-31 | 1,042,237 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 3,051,561 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 5,919,042 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 1,599,146 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 4,609,558 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 1,400,564 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 2,632,387 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 1,045,177 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 2,806,644 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 2,946,099 | shares | |
| At 2023-12-31 | 2,008,689 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 31,664,226 | USD | |
| At 2023-12-31 | 29,489,055 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 291,057 | USD | |
| At 2023-12-31 | 333,904 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2024-09-30 | 314,257 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-09-30 | 3,536,830 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 328,995 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 963,642 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 265,553 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 730,186 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 3,667 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 4,828 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | -732,521 | USD | 92 |
| 2024-01-01 to 2024-09-30 | -1,627,286 | USD | 274 |
| 2023-07-01 to 2023-09-30 | -193,608 | USD | 92 |
| 2023-01-01 to 2023-09-30 | -342,665 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-01-01 to 2024-09-30 | 79,682 | USD | 274 |
| 2023-01-01 to 2023-09-30 | 102,373 | USD | 273 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2024-07-01 to 2024-09-30 | 23,156 | USD | 92 |
| 2024-01-01 to 2024-09-30 | 68,345 | USD | 274 |
| 2023-07-01 to 2023-09-30 | 31,113 | USD | 92 |
| 2023-01-01 to 2023-09-30 | 73,884 | USD | 273 |
Inspect the source
- Entity
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. / CIK 0001757499
- Captured
- 2026-09-21T17:26:13.691Z
- SEC response SHA-256
f49398c3e7cd3b164788dc7de69572106cc3dd5ae8796315796502dfdc662883
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001757499.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))